STIM1 and breast carcinoma: First, we individually generated tamoxifen-resistant (TamR) clones derived from three estrogen receptor alpha (ESR1)-positive breast cancer cell lines MCF-7, T-47D, and BT-474 by exposing them to 2 μM Tam for a period of over 15 months.